Analysts expect Diamond Offshore Drilling (NYSE:DO) to report ($0.26) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Nine analysts have issued estimates for Diamond Offshore Drilling’s earnings. The highest EPS estimate is $0.07 and the lowest is ($0.46). Diamond Offshore Drilling posted earnings per share of $0.45 during the same quarter last year, which indicates a negative year-over-year growth rate of 157.8%. The firm is expected to announce its next quarterly earnings results on Monday, July 30th.
On average, analysts expect that Diamond Offshore Drilling will report full year earnings of ($0.53) per share for the current financial year, with EPS estimates ranging from ($0.95) to ($0.05). For the next financial year, analysts expect that the business will post earnings of ($0.30) per share, with EPS estimates ranging from ($0.65) to $0.10. Zacks’ earnings per share calculations are a mean average based on a survey of research firms that follow Diamond Offshore Drilling.
Top 5 Growth Stocks To Own Right Now: Buffalo Wild Wings Inc.(BWLD)
Advisors' Opinion:- [By Peter Graham]
A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen's clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby's Restaurant Group:
- [By Steve Symington]
That's not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.
Top 5 Growth Stocks To Own Right Now: TrueBlue Inc.(TBI)
Advisors' Opinion:- [By Max Byerly]
Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Trueblue Inc (NYSE:TBI) by 18.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,550 shares of the business services provider’s stock after purchasing an additional 4,700 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Trueblue were worth $823,000 as of its most recent filing with the Securities & Exchange Commission.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Trueblue (TBI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.
- [By Motley Fool Transcribers]
TrueBlue Inc (NYSE:TBI)Q4 2018 Earnings Conference CallFeb. 07, 2019, 5:00 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Stephan Byrd]
Russell Investments Group Ltd. grew its stake in Trueblue Inc (NYSE:TBI) by 21.2% during the first quarter, HoldingsChannel reports. The fund owned 137,178 shares of the business services provider’s stock after purchasing an additional 23,951 shares during the quarter. Russell Investments Group Ltd.’s holdings in Trueblue were worth $3,553,000 at the end of the most recent quarter.
Top 5 Growth Stocks To Own Right Now: Intuitive Surgical Inc.(ISRG)
Advisors' Opinion:- [By Lisa Levin] Gainers vTv Therapeutics Inc. (NASDAQ: VTVT) shares surged 115 percent to $2.56. Seadrill Limited (NYSE: SDRL) gained 77 percent to $0.3935. On Tuesday, a U.S. court approved the company's plan to exit Chapter 11 bankruptcy that includes raising around $1 billion in new debt and equity through a rights offering which will be led by its biggest shareholder. DropCar, Inc. (NASDAQ: DCAR) shares climbed 21.4 percent to $2.3301 after the company issued a preliminary Q1 update on its enterprise automotive business. The company disclosed that Q1 B2B automotive volumes rose 163 percent year-over-year. Teligent, Inc. (NASDAQ: TLGT) shares jumped 19.7 percent to $3.615 following the FDA approval of Clobetasol Propionate Cream USP, 0.05%. IZEA, Inc. (NASDAQ: IZEA) surged 19.1 percent to $2.62. IZEA posted a Q4 net loss of $743,000 on sales of $6.8 million. SunPower Corporation (NASDAQ: SPWR) shares gained 15.2 percent to $9.6180. SunPower announced plans to acquire SolarWorld Americas. LexinFintech Holdings Ltd. (NASDAQ: LX) climbed 10.2 percent to $15.20. CounterPath Corporation (NASDAQ: CPAH) shares rose 8.8 percent to $3.0033. Semiconductor Manufacturing International Corporation (NYSE: SMI) gained 8.2 percent to $6.685 after falling 0.80 percent on Tuesday. Energy XXI Gulf Coast, Inc. (NASDAQ: EGC) shares climbed 7.2 percent to $5.93. Textron Inc. (NYSE: TXT) shares rose 6.7 percent to $63.96 after the company reported stronger-than-expected earnings for its first quarter. Sibanye Gold Limited (NYSE: SBGL) gained 6.5 percent to $3.59 after dropping 4.53 percent on Tuesday. Calithera Biosciences, Inc. (NASDAQ: CALA) rose 6.3 percent to $6.75 after the company disclosed that the FDA has granted Fast Track designation to CB-839 in combination with cabozantinib for treatment of patients with advanced renal cell carcinoma. CSX Corporation (NASDAQ: CSX) gained 6.1 percent to $60.01 after reporting upbeat quarterly earnings
- [By Anders Bylund, Leo Sun, and Demitrios Kalogeropoulos]
Read on to see why you should forget about bitcoin and Ethereum in favor of Taiwan Semiconductor (NYSE:TSM), eBay (NASDAQ:EBAY), and Intuitive Surgical (NASDAQ:ISRG) -- at least when it comes to serious investments for the long term.
- [By Brian Feroldi]
TransEnterix (NYSEMKT:TRXC) recently surprised investors on the upside when it reported its first-quarter results. The company's Senhance surgical system is off to a fast start right out of the gate, and it has attracted a lot of positive attention from the medical community. This just goes to show how much demand is out there for an alternative to Intuitive Surgical's (NASDAQ: ISRG) dominant da Vinci platform.
Top 5 Growth Stocks To Own Right Now: Nordstrom Inc.(JWN)
Advisors' Opinion:- [By Dan Caplinger]
Nordstrom (NYSE:JWN) has suffered along with much of the rest of the retail industry for quite a while now, as changes in the ways shoppers like to shop have forced companies across the sector to adapt their business practices and adopt new technologies. Some had hoped that the upscale Seattle-based retailer would prove immune to those trends, but Nordstrom hasn't escaped the resulting downward pressure. Now that it seems unlikely that the Nordstrom family will succeed in pulling off a leveraged buyout of the retailer, shareholders want to feel more confident about the future direction the company will take, especially as competitors have started to show signs of a recovery.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Nordstrom (JWN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Jeremy Bowman]
A lot has changed since then, however. J.C. Penney badly underperformed its own comparable sales target in the second half of 2016, as comparable sales fell instead of hitting the 3-4% mark the company had projected. Its peers continued to struggle -- Macy's (NYSE:M), Kohl's (NYSE:KSS), and Nordstrom (NYSE:JWN) all reported declining comps in the fourth quarter, and Macy's said last year it would close 100 stores.
- [By John Ballard]
However, whether because of the tax act passed late last year, or something else, consumers are starting to shop again. And that is starting to benefit traditional department stores like Nordstrom (NYSE:JWN) and Macy's (NYSE:M). Both retailers have posted growth in comparable-store sales and have a strategy to increase their business online, where more people are choosing to shop.
- [By Steve Symington]
But several individual companies bucked the indexes' trend. Read on to learn why MiMedx Group (NASDAQ:MDXG), Core Laboratories (NYSE:CLB), and Nordstrom (NYSE:JWN) trailed the broader market today.
- [By ]
Cramer and the AAP team say today's weakness is the opportunity they have been patiently waiting for. Their target? Nordstrom (JWN) . Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
Top 5 Growth Stocks To Own Right Now: MEDIFAST INC(MED)
Advisors' Opinion:- [By Joseph Griffin]
MediBloc (CURRENCY:MED) traded 6.8% lower against the dollar during the 1-day period ending at 15:00 PM Eastern on May 27th. MediBloc has a total market cap of $73.40 million and $743,880.00 worth of MediBloc was traded on exchanges in the last 24 hours. One MediBloc token can currently be purchased for approximately $0.0247 or 0.00000339 BTC on major cryptocurrency exchanges including Bibox, Gate.io and Coinrail. During the last seven days, MediBloc has traded 8.3% higher against the dollar.
- [By Lisa Levin] Gainers Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares rose 35.8 percent to $3.00. Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares surged 32 percent to $8.94 after reporting upbeat Q1 earnings. Carbon Black, Inc. (NASDAQ: CBLK) gained 29.6 percent to $24.62. Carbon Black priced its IPO at $19 per share. California Resources Corporation (NYSE: CRC) shares rose 26.8 percent to $32.70 following upbeat Q1 earnings. Pandora Media, Inc. (NYSE: P) gained 25 percent to $7.185 after reporting strong quarterly results. Medifast, Inc. (NYSE: MED) shares climbed 23.7 percent to $122.87 after the company reported strong Q1 results and raised its FY18 guidance. Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.2 percent to $8.4999 after reporting Q2 results. Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) gained 22.2 percent to $41.27 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban. Shake Shack Inc (NYSE: SHAK) rose 22.2 percent to $57.955 after the company reported upbeat results for its first quarter and raised its FY18 guidance. Atomera Incorporated (NASDAQ: ATOM) jumped 19.7 percent to $6.12 after reporting Q1 results. Super Micro Computer, Inc. (NASDAQ: SMCI) rose 16.4 percent to $21.00 after reporting strong preliminary results for the third quarter. Titan International, Inc. (NYSE: TWI) shares rose 16.4 percent to $12.21 following Q1 earnings. Integer Holdings Corporation (NYSE: ITGR) shares gained 14.9 percent to $63.75 following Q1 results. Control4 Corporation (NASDAQ: CTRL) shares climbed 14.5 percent to $23.98 folloiwng strong Q1 results. B&G Foods, Inc. (NYSE: BGS) climbed 12.6 percent to $25.40 after reporting Q1 earnings. HMS Holdings Corp (NASDAQ: HMSY) shares gained 10 percent to $19.59 after reporting upbeat quarterly earnings. Viavi Solutions Inc. (NASDAQ: VIAV) rose 7 percent to $10.09 following Q3 r
- [By Sean Williams]
Meanwhile, Medifast's (NYSE:MED) share price has tripled since the beginning of March. Medifast's second-quarter operating results showcased a 55% increase in sales and an 84% improvement in year-over-year adjusted earnings per share. A substantial increase in Optavia-branded products sold, along with a big jump in active earning coaches, drove results. The company also substantially lifted its full-year sales and profit guidance (close to 20% at the midpoint for both measures).
No comments:
Post a Comment